• NatureSynthetic

Associated products


Our Abpromise guarantee covers the use of ab98289 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • Purity70 - 90% by HPLC.

  • FormLiquid
  • Additional notes

    - First try to dissolve a small amount of peptide in either water or buffer. The more charged residues on a peptide, the more soluble it is in aqueous solutions.
    - If the peptide doesn’t dissolve try an organic solvent e.g. DMSO, then dilute using water or buffer.
    - Consider that any solvent used must be compatible with your assay. If a peptide does not dissolve and you need to recover it, lyophilise to remove the solvent.
    - Gentle warming and sonication can effectively aid peptide solubilisation. If the solution is cloudy or has gelled the peptide may be in suspension rather than solubilised.
    - Peptides containing cysteine are easily oxidised, so should be prepared in solution just prior to use.

  • Concentration information loading...

Preparation and Storage

  • Stability and Storage

    Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.

    Information available upon request.

General Info

  • Alternative names
    • Matrix metallopeptidase 14 (membrane inserted)
    • Matrix metalloproteinase 14
    • Matrix metalloproteinase-14
    • Membrane type 1 matrix metalloproteinase
    • Membrane type 1 metalloprotease
    • Membrane type matrix metalloproteinase 1
    • Membrane-type matrix metalloproteinase 1
    • Membrane-type-1 matrix metalloproteinase
    • MMP 14
    • MMP X1
    • MMP-14
    • MMP-X1
    • Mmp14
    • MMP14_HUMAN
    • MMPX1
    • MT MMP 1
    • MT-MMP 1
    • MT1 MMP
    • MT1-MMP
    • MT1MMP
    • MTMMP 1
    • MTMMP1
    see all
  • FunctionSeems to specifically activate progelatinase A. May thus trigger invasion by tumor cells by activating progelatinase A on the tumor cell surface. May be involved in actin cytoskeleton reorganization by cleaving PTK7.
  • Tissue specificityExpressed in stromal cells of colon, breast, and head and neck. Expressed in lung tumors.
  • Sequence similaritiesBelongs to the peptidase M10A family.
    Contains 4 hemopexin-like domains.
  • DomainThe conserved cysteine present in the cysteine-switch motif binds the catalytic zinc ion, thus inhibiting the enzyme. The dissociation of the cysteine from the zinc ion upon the activation-peptide release activates the enzyme.
  • Post-translational
    The precursor is cleaved by a furin endopeptidase.
  • Cellular localizationMembrane. Melanosome. Identified by mass spectrometry in melanosome fractions from stage I to stage IV.
  • Information by UniProt

References for Human MMP14 peptide (ab98289)

ab98289 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab98289.
Please use the links above to contact us or submit feedback about this product.